Avery Schumer
All posts from Avery Schumer
Avery Schumer in Insider trading,

Time To Buy Synergy Pharma, Roth Capital Says

The share price of Synergy Pharmaceuticals Inc  has appreciated by 88.35 percent over the last six months, from a low of $3.44 on May 5.

Roth Capital’s Michael Higgins has reinitiated coverage of the company with a Buy rating and price target of $9.50.

will you take a chance on this?